Patent application number | Description | Published |
20080243144 | METHODS AND SYSTEMS FOR MANIPULATING TISSUE - An endoluminal treatment device and method includes introducing an endoluminal device into a lumen of a patient and engaging a wall of the lumen with an implant device. The implant device can be a drug delivery device or medical device. | 10-02-2008 |
20080312729 | METHODS OF TISSUE RECONFIGURATION - An endoluminal treatment device and method includes introducing an endoluminal device into a lumen of a patient and engaging a wall of the lumen with an implant device. The implant device can be a drug delivery device or medical device. | 12-18-2008 |
20080312750 | METHODS AND DEVICES FOR RECONFIGURING A BODY ORGAN - An endoluminal treatment device and method includes introducing an endoluminal device into a lumen of a patient and engaging a wall of the lumen with an implant device. The implant device can be a drug delivery device or medical device. | 12-18-2008 |
20090018389 | METHODS AND SYSTEMS FOR TISSUE MANIPULATION - An endoluminal treatment device and method includes introducing an endoluminal device into a lumen of a patient and engaging a wall of the lumen with an implant device. The implant device can be a drug delivery device or medical device. | 01-15-2009 |
20090018558 | METHODS OF ORGAN RECONFIGURATION - An endoluminal treatment device and method includes introducing an endoluminal device into a lumen of a patient and engaging a wall of the lumen with an implant device. The implant device can be a drug delivery device or medical device. | 01-15-2009 |
20090018594 | METHODS AND DEVICES FOR MEDICAL TREATMENT - An endoluminal treatment device and method includes introducing an endoluminal device into a lumen of a patient and engaging a wall of the lumen with an implant device. The implant device can be a drug delivery device or medical device. | 01-15-2009 |
20110046510 | Glucose Monitoring Device And Method - A method for determining the quantity of an analyte in a fluid is described along with various components of an apparatus designed to carry out the method. The method involves habituating a patient's eye to one or more colors, measuring the recovery time, and correlating the recovery time to the quantity of the analyte. A reproducible, objective, non-attentiveness-dependant test for assessing analyte levels is further disclosed. To this end, a device that measures saccadic eye movements may be used to assess the return of vision to the prehabituated state. The method and apparatus are particularly suited for noninvasively measuring blood glucose levels. | 02-24-2011 |